BACKGROUND: Although functional status, as assessed by the New York Heart Association classification, is known to be a powerful prognostic marker in chronic heart failure (CHF), the significance of individual symptoms such as breathlessness and fatigue are unknown. OBJECTIVE: To assess the relative importance of self-reported severity of symptoms as predictors of outcomes in CHF. METHODS AND RESULTS:All 3029 patients randomized in theCarvedilol or Metoprolol European Trial (ie, COMET) study were included in the analysis. Mean follow-up was 58 months. Symptoms were assessed by 5-point scales. In a univariate analysis, worse scores for breathlessness, orthopnea and fatigue were all significantly related to increased mortality (all P < .0001) and development of worsening heart failure. In a multivariate Cox regression analysis including 16 baseline covariates, only the symptom of breathlessness remained significantly related to mortality (risk ratio [RR] 1.14 per unit: 95% CI 1.04-1.26; P = .01). Fatigue, but not breathlessness, remained a significant predictor for developing worsening heart failure (RR 1.09 per unit; 95% CI 1.02-1.18; P = .02). CONCLUSIONS:Fatigue and breathlessness, common symptoms in CHF, have important and independent long-term prognostic implications. Accordingly, symptoms need to be effectively evaluated not only because symptom alleviation is a target for treatment, but also because they guide prognosis in patients with CHF.
RCT Entities:
BACKGROUND: Although functional status, as assessed by the New York Heart Association classification, is known to be a powerful prognostic marker in chronic heart failure (CHF), the significance of individual symptoms such as breathlessness and fatigue are unknown. OBJECTIVE: To assess the relative importance of self-reported severity of symptoms as predictors of outcomes in CHF. METHODS AND RESULTS: All 3029 patients randomized in the Carvedilol or Metoprolol European Trial (ie, COMET) study were included in the analysis. Mean follow-up was 58 months. Symptoms were assessed by 5-point scales. In a univariate analysis, worse scores for breathlessness, orthopnea and fatigue were all significantly related to increased mortality (all P < .0001) and development of worsening heart failure. In a multivariate Cox regression analysis including 16 baseline covariates, only the symptom of breathlessness remained significantly related to mortality (risk ratio [RR] 1.14 per unit: 95% CI 1.04-1.26; P = .01). Fatigue, but not breathlessness, remained a significant predictor for developing worsening heart failure (RR 1.09 per unit; 95% CI 1.02-1.18; P = .02). CONCLUSIONS:Fatigue and breathlessness, common symptoms in CHF, have important and independent long-term prognostic implications. Accordingly, symptoms need to be effectively evaluated not only because symptom alleviation is a target for treatment, but also because they guide prognosis in patients with CHF.
Authors: Lorraine S Evangelista; Solomon Liao; Marjan Motie; Nathalie De Michelis; Jennifer Ballard-Hernandez; Dawn Lombardo Journal: J Palliat Med Date: 2013-12-04 Impact factor: 2.947
Authors: Anne M Fink; Rosalia C Gonzalez; Tadeusz Lisowski; Maria Pini; Giamila Fantuzzi; Wayne C Levy; Mariann R Piano Journal: J Card Fail Date: 2012-09 Impact factor: 5.712
Authors: Debra K Moser; Kyoung Suk Lee; Jia-Rong Wu; Gia Mudd-Martin; Tiny Jaarsma; Tsuey-Yuan Huang; Xui-Zhen Fan; Anna Strömberg; Terry A Lennie; Barbara Riegel Journal: Int J Nurs Stud Date: 2014-02-28 Impact factor: 5.837
Authors: Joy R Goebel; Lynn V Doering; Lorraine S Evangelista; Adeline M Nyamathi; Sally L Maliski; Steven M Asch; Cathy D Sherbourne; Lisa R Shugarman; Andy B Lanto; Angela Cohen; Karl A Lorenz Journal: J Card Fail Date: 2008-11-13 Impact factor: 5.712
Authors: Joy R Goebel; Lynn V Doering; Karl A Lorenz; Sally L Maliski; Adeline M Nyamathi; Lorraine S Evangelista Journal: Nurs Forum Date: 2009 Jul-Sep